Regulation of Protein Diversity by Alternative Pre-mRNA Splicing with Specific Focus on Chondrogenesis

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 72, Issue 1, 2004, Pages 51-68

  McAlinden, Audrey ^a,c   Havlioglu, Necat ^b   Sandell, Linda J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Alternative splicing; Chondrogenesis; Development; RNA; Splicing factors

Indexed keywords

AGGRECAN; CELL CYCLE PROTEIN; CIS ACTING ELEMENT; COLLAGEN TYPE 1; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBRONECTIN; MESSENGER RNA PRECURSOR; SPLICING REGULATORY PROTEIN; TRANS ACTING FACTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHONDROGENESIS; DEVELOPMENTAL STAGE; GENE EXPRESSION; HUMAN; HUMAN GENOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN ISOFORMS; PROTEINS; RNA PRECURSORS;

EID: 1842422590     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20004     Document Type: Review

References (150)

1. Agrotis A, Condron M, Bobik A. 2000. Alternative splicing within the TGF-beta type I receptor gene (ALK-5) generates two major functional isoforms in vascular smooth muscle cells. FEBS Lett 467:128-132.
2. Aigner T, Zhu Y, Chansky HH, et al. 1999. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 42:1443-1450.
3. Akiyama H, Kanno T, Ito H, et al. 1999. Positive and negative regulation of chondrogenesis by splice variants of PEBP2alphaA/CBFalpha1 in clonal mouse EC cells, ATDC5. J Cell Physiol 181:169-178.
4. Ala-Kokko L, Kvist AP, Metsaranta M, et al. 1995. Conservation of the sizes of 53 introns and over 100 intronic sequences for the binding of common transcription factors in the human and mouse genes for type II procollagen (COL2A1). Biochem J 308:923-929.
5. Apte SS, Olsen BR. 1993. Characterization of the mouse type X collagen gene. Matrix 13:165-179.
6. Beck AR, Medley QG, O'Brien S, et al. 1996. Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. Nucleic Acids Res 24:3829-3835.
7. Bennett VD, Pallante KM, Adams SL. 1991. The splicing pattern of fibronectin mRNA changes during chondrogenesis resulting in an unusual form of the mRNA in cartilage. J Biol Chem 266:5918-5924.
8. Beppu H, Minowa O, Miyazono K, Kawabata M. 1997. cDNA cloning and genomic organization of the mouse BMP type II receptor. Biochem Biophys Res Commun 235:499-504.
9. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291-336.
10. Black DL, Grabowski PJ. 2003. Alternative pre-mRNA splicing and neuronal function. Prog Mol Subcell Biol 31:187-216.
11. Blanchette M, Chabot B. 1997. A highly stable duplex structure sequesters the 5′ splice site region of hnRNP A1 alternative exon 7B. RNA 3:405-419.
12. Blanchette M, Chabot B. 1999. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J 18:1939-1952.
13. Blencowe BJ. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. [erratum appears in Trends Biochem Sci 2000;25:228]. Trends Biochem Sci 25:106-110.
14. Blencowe BJ. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. [erratum appears in Trends Biochem Sci 2000;25:228]. Trends Biochem Sci 25:106-110.
15. Buckanovich RJ, Posner JB, Darnell RB. 1993. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 11:657-672.
16. Burge CB, Tuschl T, Sharp PA. 1999. Splicing of precursors to mRNAs by the spliceosomes. In: Atkins J, editor. The RNA world. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. pp 525-560.
17. Caputi M, Casari G, Guenzi S, et al. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res 22:1018-1022.
18. Carstens RP, Wagner EJ, Garcia-Blanco MA. 2000. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol Cell Biol 20:7388-7400.
19. Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285-298.
20. Cartegni L, Krainer AR. 2003. Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 10:120-15.
21. Cartegni L, Wang J, Zhu Z, et al. 2003. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571.
22. Charlet-B N, Logan P, Singh G, Cooper TA. 2002. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell 9:649-658.
23. Chen Y, Sumiyoshi H, Oxford JT, et al. 2001. Cis-acting elements regulate alternative splicing of exons 6A, 6B and 8 of the alpha1(XI) collagen gene and contribute to the regional diversification of collagen XI matrices. Matrix Biol 20:589-599.
24. Chiu IM, Touhalisky K, Baran C. 2001. Multiple controlling mechanisms of FGF1 gene expression through multiple tissue-specific promoters. Prog Nucleic Acid Res Mol Biol 70:155-174.
25. Cohen-Barak O, Hagiwara N, Arlt MF, et al. 2001. Cloning, characterization and chromosome mapping of the human SOX6 gene. Gene 265:157-164.
26. Colwill K, Pawson T, Andrews B, et al. 1996. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 15:265-275.
27. Cooper TA, Ordahl CP. 1985. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J Biol Chem 260:11140-11148.
28. Cooper TA, Cardone MH, Ordahl CP. 1988. Cis requirements for alternative splicing of the cardiactroponin T pre-mRNA. Nucleic Acids Res 16:8443-8465.
29. Cramer P, Caceres JF, Cazalla D, et al. 1999. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 4:251-258.
30. Davies GB, Oxford JT, Hausafus LC, et al. 1998. Temporal and spatial expression of alternative splice-forms of the alpha1(XI) collagen gene in fetal rat cartilage. Dev Dyn 213:12-26.
31. Deak F, Barta E, Mestric S, et al. 1991. Complex pattern of alternative splicing generates unusual diversity in the leader sequence of the chicken link protein mRNA.[erratum appears in Nucleic Acids Res 1991;19:6083-6084; PMID: 1945898]. Nucleic Acids Res 19:4983-4990.
32. Deak F, Barta E, Mestric S, et al. 1991. Complex pattern of alternative splicing generates unusual diversity in the leader sequence of the chicken link protein mRNA.[erratum appears in Nucleic Acids Res 1991;19:6083-6084; PMID: 1945898]. Nucleic Acids Res 19:4983-4990.
33. de Crombrugghe B, Lefebvre V, Nakashima K. 2001. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 13:721-727.
34. Del Gatto F, Breathnach R. 1995. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol Cell Biol 15:4825-4834.
35. Del Gatto-Konczak F, Olive M, Gesnel MC, Breathnach R. 1999. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol Cell Biol 19:251-260.
36. Del Gatto-Konczak F, Bourgeois CF, Le Guiner C, et al. 2000. The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. Mol Cell Biol 20:6287-6299.
37. Dirks RP, Potter SJ, Griep AE. 2001. Novel fibroblast growth factor 2 transcripts are expressed in mouse embryos. Biochem Biophys Res Commun 287:900-909.
38. Dundr M, Misteli T. 2001. Functional architecture in the cell nucleus. Biochem J 356:297-310.
39. Eckhart L, Henry M, Santos-Beneit AM, et al. 2001. Alternative splicing of caspase-8 mRNA during differentiation of human leukocytes. Biochem Biophys Res Commun 289:777-781.
40. Eswarakumar VP, Monsonego-Ornan E, Pines M, et al. 2002. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793.
41. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. 2002. Predictive identification of exonic splicing enhancers in human genes. Science 297:1007-1013.
42. Flannery CR, Hughes CE, Schumacher BL, et al. 1999. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun 254:535-541.
43. Forch P, Puig O, Martinez C, et al. 2002. The Splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. EMBO J 21:6882-6892.
44. Fujita H, Ohta M, Kawasaki T, Itoh N. 1991. The expression of two isoforms of the human fibroblast growth factor receptor (flg) is directed by alternative splicing. Biochem Biophys Res Commun 174:946-951.
45. Fulop C, Walcz E, Valyon M, Glant TT. 1993. Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel module. J Biol Chem 268:17377-17383.
46. Fulop C, Cs-Szabo G, Glant TT. 1996. Species-specific alternative splicing of the epidermal growth factor-like domain 1 of cartilage aggrecan. Biochem J 319:935-940.
47. Gallego ME, Sirand-Pugnet P, Durosay P, et al. 1996. Tissue-specific splicing of two mutually exclusive exons of the chicken beta-tropomyosin pre-mRNA: positive and negative regulations. Biochimie 78:457-465.
48. Garcia-Blanco MA, Jamison SF, Sharp PA. 1989. Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns. Genes Dev 3:1874-1886.
49. Gehris AL, Brandli DW, Lewis SD, Bennett VD. 1996. The exon encoding the fibronectin type III-9 repeat is constitutively included in the mRNA from chick limb mesenchyme and cartilage. Biochim Biophys Acta 1311:5-12.
50. Gehris AL, Stringa E, Spina J, et al. 1997. The region encoded by the alternatively spliced exon IIIA in mesenchymal fibronectin appears essential for chondrogenesis at the level of cellular condensation. Dev Biol 190:191-205.
51. Gemel J, Gorry M, Ehrlich GD, MacArthur CA. 1996. Structure and sequence of human FGF8. Genomics 35:253-257.
52. Gluhak J, Mais A, Mina M. 1996. Tenascin-C is associated with early stages of chondrogenesis by chick mandibular ectomesenchymal cells in vivo and in vitro. Dev Dyn 205:24-40.
53. Goldstrohm AC, Greenleaf AL, Garcia-Blanco MA. 2001. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277:31-47.
54. Gooding C, Roberts GC, Moreau G, et al. 1994. Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon. EMBO J 13:3861-3872.
55. Grabowski PJ, Black DL. 2001. Alternative RNA splicing in the nervous system. Prog Neurobiol 65:289-308.
56. Graveley BR, Maniatis T. 1998. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell 1:765-771.
57. Graveley BR. 2000. Sorting out the complexity of SR protein functions. RNA 6:1197-1211.
58. Gui JF, Tronchere H, Chandler SD, Fu XD. 1994. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc Natl Acad Sci USA 91:10824-10828.
59. Hatano H, Sarkar G, Bolander ME. 2002. Development of a cellular model to study alternative splicing of type II collagen gene. J Orthop Res 20:516-519.
60. Hau P, Wise P, Bosserhoff AK, et al. 2002. Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIAY CD-RAP). J Invest Dermatol 119:562-569.
61. Hertel KJ, Lynch KW, Maniatis T. 1997. Common themes in the function of transcription and splicing enhancers. Curr Opin Cell Biol 9:350-357.
62. Hoffman BE, Grabowski PJ. 1992. U1 snRNP targets an essential splicing factor, U2AF65, to the 3′ splice site by a network of interactions spanning the exon. Genes Dev 6:2554-2568.
63. Hou VC, Conboy JG. 2001. Regulation of alternative pre-mRNA splicing during erythroid differentiation. Curr Opin Hematol 8:74-79.
64. Ikeda T, Zhang J, Chano T, et al. 2002. Identification and characterization of the human long form of Sox5 (L-SOX5) gene. Gene 298:59-68.
65. Ingersoll RG, Paznekas WA, Tran AK, et al. 2001. Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations. Cytogenet Cell Genet 94:121-126.
66. Joun H, Lanske B, Karperien M, et al. 1997. Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: a new PTH/PTHrP receptor splice variant that lacks the signal peptide. Endocrinology 138:1742-1749.
67. Juvonen M, Sandberg M, Pihlajaniemi T. 1992. Patterns of expression of the six alternatively spliced exons affecting the structures of the COL1 and NC2 domains of the alpha 1(XIII) collagen chain in human tissues and cell lines. J Biol Chem 267:24700-24707.
68. Karsenty G, Wagner EF. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
69. Karsenty G. 2003. The complexities of skeletal biology. Nature 423:316-318.
70. Krecic AM, Swanson MS. 1999. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11:363-371.
71. Kulyk WM, Upholt WB, Kosher RA. 1989. Fibronectin gene expression during limb cartilage differentiation. Development 106:449-455.
72. Kuo BA, Uporova TM, Liang H, et al. 2002. Alternative splicing during chondrogenesis: modulation of fibronectin exon EIIIA splicing by SR proteins. J Cell Biochem 86:45-55.
73. Ladd AN, Charlet N, Cooper TA. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 21:1285-1296.
74. Ladd AN, Cooper TA. 2002. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol 3:reviews0008.
75. Larrain J, Bachiller D, Lu B, et al. 2000. BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development 127:821-830.
76. Lavigueur A, La Branche H, Kornblihtt AR, Chabot B. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev 7:2405-2417.
77. Lefebvre V, Li P, de Crombrugghe B. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-57133.
78. Lefkoe TP, Nalin AM, Clark JM, et al. 1997. Gene expression of collagen types IIA and IX correlates with ultrastructural events in early osteoarthrosis: new applications of the rabbit meniscectomy model. J Rheumatol 24:1155-1163.
79. Libri D, Piseri A, Fiszman MY. 1991. Tissue-specific splicing in vivo of the beta-tropomyosin gene: dependence on an RNA secondary structure. Science 252:1842-1845.
80. Liu CY, Olsen BR, Kao WW. 1993. Developmental patterns of two alpha 1(IX) collagen mRNA isoforms in mouse. Dev Dyn 198:150-157.
81. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. 1987. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 105:2569-2579.
82. Mackie EJ, Murphy LI. 1998. The role of tenascin-C and related glycoproteins in early chondrogenesis. Microsc Res Tech 43:102-110.
83. Madigou T, Uzbekova S, Lareyre JJ, Kah O. 2002. Two messenger RNA isoforms of the gonadotrophin-releasing hormone receptor, generated by alternative splicing and/or promoter usage, are differentially expressed in rainbow trout gonads during gametogenesis. Mol Reprod Dev 63:151-160.
84. Mariani FV, Martin GR. 2003. Deciphering skeletal patterning: clues from the limb. Nature 423:319-325.
85. Markovtsov V, Nikolic JM, Goldman JA, et al. 2000. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol 20:7463-7479.
86. Maroney PA, Romfo CM, Nilsen TW. 2000. Functional recognition of 5′ splice site by U4/U6.U5 tri-snRNP defines a novel ATP-dependent step in early spliceosome assembly. Mol Cell 6:317-328.
87. Matsui Y, Araki N, Tsuboi H, et al. 2002. Differential expression of aggrecan mRNA isoforms by chondrosarcoma cells. Anticancer Res 22:4169-4172.
88. McAlinden A, Wu J, Sandell LJ. 2004. Differential regulation of type IIA procollagen exon 2 inclusion by nuclear RNA splicing factors. Trans Orthop Res Soc 29:(in press).
89. Mendoza C, Olguin P, Lafferte G, et al. 2003. Novel isoforms of Dlg are fundamental for neuronal development in Drosophila. J Neurosci 23:2093-2101.
90. Millet C, Lemaire P, Orsetti B, et al. 2001. The human chordin gene encodes several differentially expressed spliced variants with distinct BMP opposing activities. Mech Dev 106:85-96.
91. Misteli T. 2000. Cell biology of transcription and pre-mRNA splicing: nuclear architecture meets nuclear function. J Cell Sci 113:1841-1849.
92. Morris NP, Bachinger HP. 1987. Type XI collagen is a heterotrimer with the composition (1 alpha, 2 alpha, 3 alpha) retaining non-triple-helical domains. J Biol Chem 262:11345-11350.
93. Murphy LI, Fischer D, Chiquet-Ehrismann R, Mackie EJ. 2000. Tenascin-C induced stimulation of chondrogenesis is dependent on the presence of the C-terminal fibrinogen-like globular domain. FEBS Lett 480:189-192.
94. Nabel-Rosen H, Volohonsky G, Reuveny A, et al. 2002. Two isoforms of the Drosophila RNA binding protein, how, act in opposing directions to regulate tendon cell differentiation. Dev Cell 2:183-193.
95. Nagel RJ, Lancaster AM, Zahler AM. 1998. Specific binding of an exonic splicing enhancer by the pre-mRNA splicing factor SRp55. RNA 4:11-23.
96. Nah HD, Niu Z, Adams SL. 1994. An alternative transcript of the chick type III collagen gene that does not encode type III collagen. J Biol Chem 269:16443-16448.
97. Nah HD, Bennett VD, Niu Z, Adams SI. 1996. Alternative transcript of the chick alpha 2(I) collagen gene is transiently expressed during endochondral bone formation and during development of the central nervous system. Dev Dyn 206:146-158.
98. Neubauer G, King A, Rappsilber J, et al. 1998. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet 20:46-50.
99. Ng LJ, Tam PP, Cheah KS. 1993. Preferential expression of alternatively spliced mRNAs encoding type II procollagen with a cysteine-rich amino-propeptide in differentiating cartilage and nonchondrogenic tissues during early mouse development. Dev Biol 159:403-417.
100. Nilsen TW. 1996. A parallel spliceosome. Science 273:1813.
101. Nishimura I, Muragaki Y, Olsen BR. 1989. Tissue-specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters. J Biol Chem 264:20033-20041.
102. Nishiyama T, Hatano H, Kurosaka M, et al. 2003. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene. J Bone Miner Res 18:1716-1722.
103. Norton PA, Uporova T, Bennett VD. 1998. A highly conserved region upstream of the fibronectin alternative exon EIIIA 3' splice site interacts with cell-type-specific nuclear proteins. Biochim Biophys Acta 1395:145-150.
104. Oklu R, Hesketh TR, Metcalfe JC, Kemp PR. 1998. Expression of alternatively spliced human latent transforming growth factor beta binding protein-1. FEBS Lett 435:143-148.
105. Pace J, Corrado M, Missero C, Byers P. 2003. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol 22:3-14.
106. Pacifici M, Iwamoto M, Golden EB, et al. 1993. Tenascin is associated with articular cartilage development. Dev Dyn 198:123-134.
107. Pallante KM, Niu Z, Zhao Y, et al. 1996. The chick alpha2(I) collagen gene contains two functional promoters, and its expression in chondrocytes is regulated at both transcriptional and post-transcriptional levels. J Biol Chem 271:25233-25239.
108. Patton JG, Mayer SA, Tempst P, Nadal-Ginard B. 1991. Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev 5:1237-1251.
109. Petersen W, Tsokos M, Pufe T. 2002. Expression of VEGF121 and VEGF165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage. J Anat 201:153-157.
110. Rahman L, Bliskovski V, Reinhold W, Zajac-Kaye M. 2002. Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles. Genomics 80:245-249.
111. Ramchatesingh J, Zahler AM, Neugebauer KM, et al. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol 15:4898-4907.
112. Rappsilber J, Ryder U, Lamond AI, Mann M. 2002. Large-scale proteomic analysis of the human spliceosome. Genome Res 12:1231-1245.
113. Rhodes C, Doege K, Sasaki M, Yamada Y. 1988. Alternative splicing generates two different mRNA species for rat link protein. J Biol Chem 263:6063-6067.
114. Robinson CJ, Stringer SE. 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114:853-865.
115. Roesser JR, Liittschwager K, Leff SE. 1993. Regulation of tissue-specific splicing of the calcitonin/calcitonin gene-related peptide gene by RNA-binding proteins. J Biol Chem 268:8366-8375.
116. Rotzer D, Roth M, Lutz M, et al. 2001. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J 20:480-490.
117. Ryan KJ, Cooper TA. 1996. Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol Cell Biol 16:4014-4023.
118. Ryan MC, Sandell LJ. 1990. Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem 265:10334-10339.
119. Sahni M, Ambrosetti DC, Mansukhani A, Gertnew R, Levy D, Basilico C. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. 13:1361-1366.
120. Salminen H, Vuorio E, Saamanen AM. 2001. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum 44:947-955.
121. Sandell LJ, Morris N, Robbins JR, Goldring MB. 1991. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 114:1307-1319.
122. Sandell LJ, Okazaki K. 2004. Overview of connective tissue genes: extracellular matrix gene regulation. Clin Orthop (in press).
123. Savontaus H, Ihanamaki T, Perala M, et al. 1998. Expression of type II and IX collagen isoforms during normal and pathological cartilage and eye development. Histochem Cell Biol 110:149-159.
124. Schaal TD, Maniatis T. 1999. Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol Cell Biol 19:261-273.
125. Shimizu A, Tada K, Shukunami C, et al. 2001. A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells. J Biol Chem 276:11031-11040.
126. Smith CW, Valcarcel J. 2000. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci 25:381-388.
127. Smith PJ, Spurrell EL, Coakley J, et al. 2002. An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology 143:146-154.
128. Southby J, Murphy LM, Martin TJ, Gillespie MT. 1996. Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein. Endocrinology 137:1349-1357.
129. Staffa A, Acheson NH, Cochrane A. 1997. Novel exonic elements that modulate splicing of the human fibronectin EDA exon. J Biol Chem 272:33394-33401.
130. Staley JP, Guthrie C. 1998. Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell 92:315-326.
131. Stark JM, Cooper TA, Roth MB. 1999. The relative strengths of SR protein-mediated associations of alternative and constitutive exons can influence alternative splicing. J Biol Chem 274:29838-29842.
132. Stevens SW, Ryan DE, Ge HY, et al. 2002. Composition and functional characterization of the yeast spliceosomal penta-snRNP. Mol Cell 9:31-44.
133. Sugimoto M, Kimura T, Tsumaki N, et al. 1998. Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. Cell Tissue Res 292:325-332.
134. Swiderski RE, Solursh M. 1992. Differential co-expression of long and short form type IX collagen transcripts during avian limb chondrogenesis in ovo. Development 115:169-179.
135. Szebenyi G, Savage HP, Olwin BB, Fallon IF. 1995. Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning. Dev Dyn 204:446-456.
136. Sztrolovics R, Grover I, Cs-Szabo G, et al. 2002. The characterization of versican and its message in human articular cartilage and intervertebral disc. J Orthop Res 20:257-266.
137. Tange TO, Damgaard CK, Guth S, et al. 2001. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J 20:5748-5758.
138. Tsumaki N, Kimura T. 1995. Differential expression of an acidic domain in the amino-terminal propeptide of mouse pro-alpha 2(XI) collagen by complex alternative splicing. J Biol Chem 270:2372-2378.
139. Uporova TM, Norton PA, Tuan RS, Bennett VD. 1999. Alternative splicing during chondrogenesis: cis and trans factors involved in splicing of fibronectin exon EIIIA. J Cell Biochem 76:341-351.
140. Valcarcel J, Green MR. 1996. The SR protein family: pleiotropic functions in pre-mRNA splicing. Trends Biochem Sci 21:296-301.
141. van der Rest M, Mayne R. 1988. Type IX collagen proteoglycan from cartilage is covalently cross-linked to type II collagen. J Biol Chem 263:1615-1618.
142. Voulgaropoulou F, Myers RL, Chiu IM. 1994. Alternative splicing of fibroblast growth factor 1 (FGF-1) transcripts: a cellular dilemma in determining exon selection and exclusion. DNA Cell Biol 13:1001-1009.
143. Wagener R, Kobbe B, Paulsson M. 1998. Matrilin-4, a new member of the matrilin family of extracellular matrix proteins. FEBS Lett 436:123-127.
144. Wang HY, Lin W, Dyck JA, et al. 1998. SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol 140:737-750.
145. White DG, Hershey HP, Tuan RS, Bennett VD. 2003. Functional analysis of fibronectin isoforms of developing embryonic limb: reduced spreading of chondrogenic mesenchymal cells on full-length recombinant mesenchymal fibronectin compared to alternatively spliced isoforms. Differentiation 71:251-261.
146. Wu JJ, Eyre DR. 1995. Structural analysis of cross-linking domains in cartilage type XI collagen. Insights on polymeric assembly. J Biol Chem 270:18865-18870.
147. Xiao SH, Manley JL. 1998. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2. EMBO J 17:6359-6367.
148. Yang YY, Yin GL, Darnell RB. 1998. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci USA 95:13254-13259.
149. Zhu J, Mayeda A, Krainer AR. 2001. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell 8:1351-1361.
150. Zhu Y, Oganesian A, Keene DR, Sandell LJ. 1999. Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol 144:1069-1080.